Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

38.75
Delayed Data
As of Aug 18
 -0.30 / -0.77%
Today’s Change
37.20
Today|||52-Week Range
44.58
+0.62%
Year-to-Date

Today’s Trading

Previous close39.05
Today’s open38.96
Day’s range38.71 - 38.98
Volume2,460,202
Average volume (3 months)2,824,206
Market cap$95.3B
Dividend yield6.42%
Data as of 4:02pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+13.93%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+2.85%
P/E ratio49.2
Price/Sales2.52
Price/Book67.90

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.35-0.62%
CELGCelgene+0.07+0.05%
NVONovo Nordisk-0.16-0.35%
LLYEli Lilly and Co-0.73-0.94%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts